Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS.
Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS.